<DOC>
	<DOCNO>NCT00929734</DOCNO>
	<brief_summary>The purpose study investigate whether rosuvastatin improve measure endothelial function , decrease measure inflammation , improve pulmonary function patient stable chronic obstructive pulmonary disease .</brief_summary>
	<brief_title>Effect Rosuvastatin Therapy Patients With Stable Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>Inclusion criterion : Stable COPD patient gender COPD exacerbation less three week prior inclusion COPD stage I IV GOLD criterion ( Global Initiative Chronic Obstructive Lung Disease ) Age 40 80 year Exclusion criterion : Diagnosed lung disease COPD , except chronic asthmatic bronchitis mild bronchiectasis without physical sign ( diagnose high resolution CT ) History active coronary artery disease ( CAD ) , cerebrovascular peripheral vascular disease History clinically significant congestive heart failure , valvular heart disease , clinically significant arrhythmias conduction delay History uncontrolled arterial hypertension ( define blood pressure above180/110 mmHg without use antihypertensive medication ) Body mass index &gt; 40kg/m2 History diabetes mellitus , measure fast glucose &gt; 11 mmol/L History Hypercholesterolemia , measure total cholesterol &gt; 8 mmol/L Known poliomyelitis , motor neurone disease , cranial temporal arteritis , stroke myopathy Neutropenia , anemia ( Hb &lt; 8 g/100mL ) History chronic renal failure , serum creatinine &gt; 176 micromol/L ( 2.0mg/dL ) Creatine kinase &gt; 3 time upper limit normal ( ULN ) Acute chronic liver disease ( serum transaminase &gt; 3 time ULN ) Pregnancy ( oral examination blood test prior inclusion ) Active abuse drug alcohol , poor compliance anticipate Statin use within last 4 week prior study start previously clear indication statin use Prior diagnosis statin induce myopathy hypersensitivity reaction another hydroxymethylglutarylCoenzyme Areductase inhibitor incl . Rosuvastatin History malignant disease kind within 5 year prior inclusion . History uncontrolled hypothyroidism Participation another pharmaceutical medical device clinical trial study le 4 week prior inclusion . Use concomitant medication know interact Crestor . This include following medication : Warfarin coumarin ( vitamin K antagonist ) anticoagulant , Cyclosporin , Gemfibrozil Antacid</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Inflammation</keyword>
	<keyword>Atherosclerosis</keyword>
	<keyword>Hydroxymethylglutaryl-coenzyme A Reductase Inhibitors</keyword>
</DOC>